{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T07:44:15Z","timestamp":1788335055266,"version":"build-2803163510"},"reference-count":20,"publisher":"IMR Press","issue":"4","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Tianjin Municipal Health Commission Science and Technology Project","award":["TJWJ2022MS022"],"award-info":[{"award-number":["TJWJ2022MS022"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br. J. Hosp. Med. (Lond)"],"abstract":"<jats:p>Aims\/Background: Pharmacological therapy can enhance the therapeutic efficacy of radiofrequency ablation (RFA) for atrial fibrillation (AF) and reduce the risk of recurrence. Dronedarone and amiodarone are two commonly prescribed adjuvant medications. However, no consensus exists on which agent demonstrates superior efficacy. This study aimed to compare the effects of dronedarone and amiodarone on the prognosis of patients undergoing RFA for AF, thereby providing evidence-based guidance for clinical medication selection. Methods: A retrospective analysis was conducted on AF patients who underwent RFA in Tianjin Fourth Central Hospital between August 2022 and May 2023. Patients were assigned to a dronedarone group (n = 50), and an amiodarone group (n = 59) based on the postoperative medication received. Postoperatively, patients were treated with either dronedarone hydrochloride tablets or amiodarone hydrochloride tablets for 6 months. Long-term electrocardiographic monitoring (7-day duration via 5G network) was performed at 1, 3, 6, and 12 months postoperatively to assess recurrence of atrial arrhythmias. Follow-up assessments at the same intervals included thyroid, liver, and renal function, left atrial diameter (LAD), left ventricular ejection fraction (LVEF), and QT interval. Results: No statistically significant difference was observed in AF recurrence between the two groups (p &gt; 0.05). The incidence of thyroid dysfunction was significantly lower in the dronedarone group compared with the amiodarone group (p &lt; 0.05), whereas other adverse events showed no significant difference (p &gt; 0.05). In both groups, postoperative LVEF was significantly higher than preoperative values (p &lt; 0.05), and LAD was significantly reduced (p &lt; 0.05). Comparing the two groups, postoperative LAD was significantly smaller in the dronedarone group than in the amiodarone group (p &lt; 0.05), while postoperative LVEF exhibited no statistically significant difference (p &gt; 0.05). Conclusion: Dronedarone and amiodarone are similarly effective in reducing the AF recurrence after RFA. However, dronedarone is associated with a lower risk of thyroid dysfunction and confers greater improvement in left atrial remodelling.<\/jats:p>","DOI":"10.31083\/bjhm53024","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:17:23Z","timestamp":1777457843000},"source":"Crossref","is-referenced-by-count":1,"title":["Retrospective Analysis of Dronedarone Versus Amiodarone on Outcomes Following Radiofrequency Ablation for Atrial Fibrillation"],"prefix":"10.31083","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7517-0256","authenticated-orcid":true,"given":"Yun","family":"Shi","sequence":"first","affiliation":[{"name":"Department of Cardiology, Tianjin Fourth Central Hospital, The Affiliated Hospital of Tianjin Medical University, 300192 Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3586-2773","authenticated-orcid":true,"given":"Xueying","family":"Shi","sequence":"additional","affiliation":[{"name":"Research Department, Characteristic Medical Center of PAP, 300162 Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0558-3256","authenticated-orcid":true,"given":"Huanming","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tianjin Fourth Central Hospital, The Affiliated Hospital of Tianjin Medical University, 300192 Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1804-0355","authenticated-orcid":true,"given":"Xiufeng","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tianjin Fourth Central Hospital, The Affiliated Hospital of Tianjin Medical University, 300192 Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8140-6648","authenticated-orcid":true,"given":"Ting","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Military Patient Management, The 987th Hospital of the Joint Logistics Support Force of PLA, 721000 Baoji, Shaanxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2742-5642","authenticated-orcid":true,"given":"Guanyi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Medical Service Department, The 980th Hospital of the Joint Logistics Support Force of PLA, 050082 Shijiazhuang, Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Belpinar MS. A Global Bibliometric Analysis of Publications on Recurrent Atrial Fibrillation After Radiofrequency Ablation. Cureus. 2025; 17: e86396.","DOI":"10.7759\/cureus.86396"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Du X, Guo L, Xia S, Du J, Anderson C, Arima H, et al. Atrial fibrillation prevalence, awareness and management in a nationwide survey of adults in China. Heart. 2021; 107: 535\u2013541.","DOI":"10.1136\/heartjnl-2020-317915"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Zhou X, Xue H, Chen Q, Lv Z, Mao W, Wang X. Comparison of Myocardial Injury and Inflammation Biomarkers and Their Impact on Recurrence after Cryoballoon and Radiofrequency Ablation for Atrial Fibrillation: A Systematic Review and Meta-Analysis. Reviews in Cardiovascular Medicine. 2022; 23: 397.","DOI":"10.31083\/j.rcm2312397"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Nakanishi K, Fukuda S, Yamashita H, Kosaka M, Shirai N, Tanaka A, et al. Pre-Procedural Serum Atrial Natriuretic Peptide Levels Predict Left Atrial Reverse Remodeling After Catheter Ablation in Patients With Atrial Fibrillation. JACC. Clinical Electrophysiology. 2016; 2: 151\u2013158.","DOI":"10.1016\/j.jacep.2015.12.010"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Li Y, Hu T, Lin M, Wang Q, Han W, Zhong J. Comparison of Efficacy and Safety Between Dronedarone and Amiodarone Used During the Blind Period in Patients with Atrial Fibrillation After Catheter Ablation. Clinical Pharmacology: Advances and Applications. 2023; 15: 113\u2013123.","DOI":"10.2147\/CPAA.S440704"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Long X, Lv H, Zhang J, Wang X, Tu S, Deng X, et al. Impact of Dronedarone on Early Recurrence After Catheter Ablation in Patients With Nonparoxysmal Atrial Fibrillation. Cardiovascular Therapeutics. 2025; 2025: 2585953.","DOI":"10.1155\/cdr\/2585953"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Schweizer PA, Becker R, Katus HA, Thomas D. Dronedarone: Current Evidence for Its Safety and Efficacy in the Management of Atrial Fibrillation. Drug Design, Development and Therapy. 2011; 5: 27\u201339.","DOI":"10.2147\/DDDT.S10315"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Wu Y, Fan F, Yu J, Zhou J, Xie X, Xia G, et al. Effect of Prolonged Use of Dronedarone on Recurrence in Patients with Non-Paroxysmal Atrial Fibrillation After Radiofrequency Ablation (DORIS): Rationale and Design of a Randomized Multicenter, Double-Blinded Placebo-Controlled Trial. Cardiovascular Drugs and Therapy. 2024; 38: 1047\u20131052.","DOI":"10.1007\/s10557-023-07460-1"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Silaghi P, Eitzman DT. Resolution of Sickle Cell Crisis Following Administration of Amiodarone. European Journal of Case Reports in Internal Medicine. 2023; 10: 003879.","DOI":"10.12890\/2023_003879"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Singh JP, Blomstr\u00f6m-Lundqvist C, Turakhia MP, Camm AJ, Fazeli MS, Kreidieh B, et al. Dronedarone versus sotalol in patients with atrial fibrillation: A systematic literature review and network meta-analysis. Clinical Cardiology. 2023; 46: 589\u2013597.","DOI":"10.1002\/clc.24011"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Brophy JM, Nadeau L. Amiodarone vs Dronedarone for Atrial Fibrillation: A Retrospective Cohort Study. CJC Open. 2023; 5: 8\u201314.","DOI":"10.1016\/j.cjco.2022.09.008"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Ken-Opurum J, Srinivas SS, Vadagam P, Faith L, Park S, Charland S, et al. A value-based budget impact model for dronedarone compared with other rhythm control strategies. Journal of Comparative Effectiveness Research. 2023b; 12: e220196.","DOI":"10.57264\/cer-2022-0196"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"\u0218orodoc V, Indrei L, Dobroghii C, Asaftei A, Ceasovschih A, Constantin M, et al. Amiodarone Therapy: Updated Practical Insights. Journal of Clinical Medicine. 2024; 13: 6094.","DOI":"10.3390\/jcm13206094"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Spicher N, Klingenberg A, Purrucker V, Deserno TM. Edge computing in 5G cellular networks for real-time analysis of electrocardiography recorded with wearable textile sensors. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. 2021; 2021: 1735\u20131739.","DOI":"10.1109\/EMBC46164.2021.9630875"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Balik M, Maly M, Brozek T, Rulisek J, Porizka M, Sachl R, et al. Propafenone versus amiodarone for supraventricular arrhythmias in septic shock: a randomised controlled trial. Intensive Care Medicine. 2023; 49: 1283\u20131292.","DOI":"10.1007\/s00134-023-07208-3"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Wharton JM, Piccini JP, Koren A, Huse S, Ronk CJ. Comparative Safety and Effectiveness of Sotalol Versus Dronedarone After Catheter Ablation for Atrial Fibrillation. Journal of the American Heart Association. 2022; 11: e020506.","DOI":"10.1161\/JAHA.120.020506"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Vamos M, Oldgren J, Nam GB, Lip GYH, Calkins H, Zhu J, et al. Dronedarone vs. placebo in patients with atrial fibrillation or atrial flutter across a range of renal function: a post hoc analysis of the ATHENA trial. European Heart Journal. Cardiovascular Pharmacotherapy. 2022; 8: 363\u2013371.","DOI":"10.1093\/ehjcvp\/pvab090"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Wilson H, Patton D, Moore Z, O\u2019Connor T, Nugent L. Comparison of dronedarone vs. flecainide in the maintenance of sinus rhythm, following electrocardioversion in adults with persistent atrial fibrillation: a systematic review and meta-analysis. European Heart Journal. Cardiovascular Pharmacotherapy. 2021; 7: 363\u2013372.","DOI":"10.1093\/ehjcvp\/pvaa018"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Bejarano-Arosemena R, Mart\u00ednez-Sell\u00e9s M. Interatrial Block, Bay\u00e9s Syndrome, Left Atrial Enlargement, and Atrial Failure. Journal of Clinical Medicine. 2023; 12: 7331.","DOI":"10.3390\/jcm12237331"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Bay\u00e9s de Luna A, Mart\u00ednez-Sell\u00e9s M, Bay\u00e9s-Gen\u00eds A, Elosua R, Baranchuk A. What every clinician should know about Bay\u00e9s syndrome. Revista Espanola De Cardiologia (English Ed.). 2020; 73: 758\u2013762.","DOI":"10.1016\/j.rec.2020.04.026"}],"container-title":["British Journal of Hospital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/BJHM\/87\/4\/10.31083\/BJHM53024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:18:25Z","timestamp":1777457905000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/BJHM\/87\/4\/10.31083\/BJHM53024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"alternative-id":["S1750-8460(26)02639-0"],"URL":"https:\/\/doi.org\/10.31083\/bjhm53024","relation":{},"ISSN":["1750-8460","1759-7390"],"issn-type":[{"value":"1750-8460","type":"print"},{"value":"1759-7390","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"article-number":"53024"}}